USRE43615EActiveUtility

Method for controlling the yeast-to-filamentous growth transition in fungi

Individually held — no corporate assignee on recordPriority: Jul 10, 2007Filed: Jan 25, 2012Granted: Aug 28, 2012
Est. expiryJul 10, 2027(~0.9 yrs left)· nominal 20-yr term from priority
A61K 31/415A61P 43/00A61K 31/425
71
PatentIndex Score
2
Cited by
24
References
2
Claims

Abstract

A method for controlling yeast-to-filamentous growth transition in fungi comprising contacting a fungal cell with an anti-fungal small molecule in an amount effective to reduce or inhibit the yeast-to-filamentous growth transition, wherein the anti-fungal small molecule is 5-(p-Bromobenzylidine)-α-isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid or an analog thereof. A method for treating fungal infections comprising contacting one or more fungal cells with an anti-fungal small molecule in an amount effective to control the fungal infection, wherein the anti-fungal small molecule is 5-(p-Bromobenzylidine)-α-isopropyl-4-oxo-2-thioxo-3-thiozolidineactic acid or an analog thereof.

Claims

exact text as granted — not AI-modified
1. A method for controlling yeast-to-filamentous growth transition in fungi comprising contacting a fungal cell with an anti-fungal small molecule in an amount effective to reduce or inhibit the yeast-to-filamentous growth transition, wherein the anti-fungal small molecule is 5-(p-Bromobenzylidine)-α-isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid, and wherein the species of the fungal cell is selected from the group consisting of Candida albicans, Candida dubliniensis, Candida tropicalis, Candida parapsilosis and Candida rugosa. 
     
     
       2. A method for treating fungal infections comprising contacting one or more fungal cells with an anti-fungal small molecule in an amount effective to control the fungal infection, wherein the anti-fungal small molecule is 5-(p-Bromobenzylidine)-α-isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid, and wherein the species of the fungal cell is selected from the group consisting of Candida albicans, Candida dubliniensis, Candida tropicalis, Candida parapsilosis and Candida rugosa.

Join the waitlist — get patent alerts

Track USRE43615E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.